- Home
- SI vs BWAY Comparison
SI vs BWAY Comparison
Compare SI & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SI
- BWAY
- Stock Information
- Founded
- SI 2009
- BWAY 2003
- Country
- SI United States
- BWAY Israel
- Employees
- SI N/A
- BWAY N/A
- Industry
- SI Medical/Dental Instruments
- BWAY Medical/Dental Instruments
- Sector
- SI Health Care
- BWAY Health Care
- Exchange
- SI Nasdaq
- BWAY Nasdaq
- Market Cap
- SI 299.6M
- BWAY 280.7M
- IPO Year
- SI 2025
- BWAY 2019
- Fundamental
- Price
- SI $14.86
- BWAY $16.06
- Analyst Decision
- SI Strong Buy
- BWAY Strong Buy
- Analyst Count
- SI 5
- BWAY 2
- Target Price
- SI $19.60
- BWAY $18.00
- AVG Volume (30 Days)
- SI 157.4K
- BWAY 77.7K
- Earning Date
- SI 09-09-2025
- BWAY 11-11-2025
- Dividend Yield
- SI N/A
- BWAY N/A
- EPS Growth
- SI N/A
- BWAY 515.14
- EPS
- SI N/A
- BWAY 0.11
- Revenue
- SI $37,324,000.00
- BWAY $46,084,000.00
- Revenue This Year
- SI N/A
- BWAY $339.49
- Revenue Next Year
- SI N/A
- BWAY $21.74
- P/E Ratio
- SI N/A
- BWAY $58.19
- Revenue Growth
- SI 64.07
- BWAY 26.50
- 52 Week Low
- SI $11.75
- BWAY $7.84
- 52 Week High
- SI $17.94
- BWAY $17.00
- Technical
- Relative Strength Index (RSI)
- SI N/A
- BWAY 60.10
- Support Level
- SI N/A
- BWAY $15.01
- Resistance Level
- SI N/A
- BWAY $17.00
- Average True Range (ATR)
- SI 0.00
- BWAY 0.66
- MACD
- SI 0.00
- BWAY -0.07
- Stochastic Oscillator
- SI 0.00
- BWAY 60.50
About SI Shoulder Innovations Inc. Common Stock
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.